|
|
|
|
| LEADER |
01974nmm a2200349 u 4500 |
| 001 |
EB001839158 |
| 003 |
EBX01000000000000001003147 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
180629 ||| eng |
| 100 |
1 |
|
|a Mark, Brian
|
| 245 |
0 |
0 |
|a GM2 gangliosidosis future treatments
|h Elektronische Ressource
|b part 2 of 2
|c Brian Mark
|
| 246 |
3 |
1 |
|a GM2 gangliosidosis future treatments. Part 2
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2017, 2017
|
| 300 |
|
|
|a 1 online resource (1 streaming video file (19 min.)
|b color, sound)
|
| 505 |
0 |
|
|a Challenges of HexA delivery with AAV -- HexM modelling and interaction with GM2 -- GM2 clearance by AAV9-Hex vectors -- HexM delivery to Sandhoff disease mice
|
| 653 |
|
|
|a Hexosaminidase A.
|
| 653 |
|
|
|a Hexosaminidases
|
| 653 |
|
|
|a Tay-Sachs disease
|
| 653 |
|
|
|a Gangliosidoses, GM2 / pathology
|
| 653 |
|
|
|a Sandhoff Disease
|
| 653 |
|
|
|a G(M2) Ganglioside
|
| 653 |
|
|
|a Tay-Sachs Disease
|
| 653 |
|
|
|a Nervous system / Diseases
|
| 653 |
|
|
|a Gangliosidoses, GM2 / drug therapy
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a Protein epidemiology : understanding human diseases at the level of protein structure and function
|
| 500 |
|
|
|a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web. - System requirements: Browser compatibility: updated Mozilla Firefox, Google Chrome, Safari or Internet Explorer 8+. Browser settings: enable JavaScript, enable cookies from the Henry Stewart Talks site. Required Desktop Browser plugins & viewers: Updated Adobe Flash Player & Adobe Acrobat Reader. Mobile device & operating system versions: Android v4.0+, iPhone 4+ (iOS v6.x+), iPad 2+ (iOS v6.x+), BlackBerry OS v7.0+, Windows Phone v6.5.1+
|
| 856 |
4 |
2 |
|u https://hstalks.com/bs/p/33
|3 Series
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/3530
|x Verlag
|z Streaming video file
|
| 082 |
0 |
|
|a 570
|